The FDA has granted accelerated approval to Modeyso (dordaviprone) for the treatment of diffuse midline glioma harboring an ...

The FDA has approved Ajovy (fremanezumab) for the prevention of episodic migraine in pediatric patients aged 6 to 17 years weighing at least 45kg.

Having a supratherapeutic INR while taking warfarin does not significantly increase the risk for brain bleeding after blunt head trauma in older adults.

Cognitive functional therapy, with or without biofeedback, is more effective than usual care for treating patients with chronic disabling low back pain.

Exposure to childhood physical or verbal abuse is similarly associated with lower mental well-being during adulthood.